UV and three derivative spectrophotometric methods for determination of ezetimibe in tablet formulation

Indian Journal of Pharmaceutical Sciences

Volumn 70, Issue 2, 2008, Pages 258-260

  Sharma, Metreyi ^a   Mhaske, Deepali ^a   Mahadik, M ^a   Kadam, S ^a   Dhaneshwar, S ^a  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

Author keywords

Ezetimibe; Third derivative spectrophotometry; UV spectrophotometry

Indexed keywords

EXCIPIENT; EZETIMIBE; METHANOL;

ACCURACY; ARTICLE; DRUG DETERMINATION; DRUG RESEARCH; INTERMETHOD COMPARISON; QUANTITATIVE ANALYSIS; SPECTROPHOTOMETRY; TABLET FORMULATION; ULTRAVIOLET RADIATION;

EID: 46349094269     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.41471     Document Type: Article

References (7)

1. Available from: http://www.en.wikipedia.org/wiki/ezetimibe.
2. Domgala BM, Leady M, Streetman DS. Ezetimibe: The first cholesterol absorption inhibitor. Pharma Ther 2003;28:191-206.
3. Sistla R, Tata VS, Kashyap YV, Chandrasekar D, Diwan PV. Development and validation of a reversed-phase HPLC method for the determination of ezetimibe in pharmaceutical dosage forms. J Pharm Biomed Anal 2005;39:517-22.
4. Patrich JE, Kosoglou T, Stauber KL, Alton KB, Maxwell SE, Zhu Y, et al. Disposition of the selective cholesterol absorption inhibitor ezetimibe in healthy male subjects. Drug Metab Dispos 2002;30:430-7.
5. Oswald S, Scheuch E, Cascorbi I, Siegmund W. A LC-MS/MS method to quantify the novel cholesterol lowering drug ezetimibe in human serum, urine and feces in healthy subjects genotyped for SLCO1B1J. J chromatogr B Analyt Technol Biomed Life Sci 2006;830:143-50.
6. Li S, Liu G, Jia J, Li X, Yu C. Liquid chromatography-negative ion electrospray tandem mass spectrometry method for the quantification of ezetimibe in human plasma. J Pharm Biomed Anal 2006;40:987-92.
7. Ojeda CB, Rojas FS. Recent developments in derivative ultraviolet/visible absorption spectrophotometry. Anal Chim Acta 2004;518:1-24.